Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
Biotechnology Innovation Organization (BIO)…
WASHINGTON, DC (January 7th, 2026) – Today, the Biotechnology Innovation Organization (BIO) announced the launch of the BIO Investment Council (BIC). The newly established council aims to serve small and emerging biotech innovators by increasing…
Learn more
BIO Statement on Changes Announced to the U.S…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO)  released the following statement on changes announced to the US childhood vaccine schedule.“American health is as unique as America itself…
Learn more
BIO Statement on December 2025 ACIP Meeting
WASHINGTON, D.C. – Phyllis Arthur, Executive Vice President and Head of Health Policy and Programs of the Biotechnology Innovation Organization (BIO) released the following statement on the December 2025 ACIP meeting.“For decades, the CDC’s Advisory…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
BIO Praises Reps. Sinema and Hollingsworth for Introducing the Fostering Innovation Act
March 22, 2017
Washington, DC (March 22, 2017) – Today, the Biotechnology Innovation Organization (BIO) applauds Reps. Kyrsten Sinema (D-AZ) and Trey Hollingsworth (R-IN) for introducing the Fostering Innovation Act. The legislation would reduce compliance…
BIO Statement on President’s Budget Proposal
March 16, 2017
Washington, DC (March 16, 2017) – BIO Senior Vice President for Communications Kenneth Lisaius issued the following statement today regarding President Trump’s budget blueprint:“While we are still reviewing today’s budget blueprint, we…
BIO Statement on Confirmation of Ms. Seema Verma
March 13, 2017
BIO congratulates Ms. Seema Verma on her successful confirmation to lead the Centers for Medicare and Medicaid Services (CMS). We look forward to working with her and Secretary Price to advance patient-centric policies that promote affordable access…
BIO President & CEO Greenwood Testifies to House Subcommittee on the Next Farm Bill
March 9, 2017
BIO President & CEO Jim Greenwood today delivered testimony to a House Committee on Agriculture, Subcommittee on Commodity Exchanges, Energy and Credit, Hearing: The Next Farm Bill: Rural Development & Energy Programs.
BIO is Now Accepting Nominations for its Fourth Annual Rosalind Franklin Award
March 8, 2017
BIO began accepting nominations for its fourth annual Rosalind Franklin Award for Leadership in Industrial Biotechnology.  Each year, this award is given to an outstanding woman in the industrial biotechnology sector who has made…
BIO Presents Sen. John Thune (R-S.D.) Legislator of the Year Award
February 28, 2017
The Biotechnology Innovation Organization (BIO) today presented Senator John Thune (R-S.D.) its Industrial & Environmental Section Legislator of the Year Award, recognizing the Senator’s steadfast commitment to growing South Dakota’s and…
BIO Submits Comments on EPA’s Proposed Denial of Petitions for Rulemaking to Change the RFS Point of Obligation
February 22, 2017
In BIO’s view, granting the petitions to change the point of obligation would create unnecessary regulatory uncertainty and fail to further the statutory goals of the Renewable Fuel Standard (“RFS”) program.
Nominations Now Open for the BIO George Washington Carver Award for Innovation in Industrial Biotechnology
February 22, 2017
The ninth annual George Washington Carver Award will recognize an individual who has made a significant contribution to building the biobased economy by applying industrial biotechnology to create sustainable and environmentally…
BIO Submits Comments on EPA Renewables Enhancement and Growth Support Rule
February 16, 2017
The Biotechnology Innovation Organization (BIO) today submitted comments on the Environmental Protection Agency’s recently proposed Renewables Enhancement and Growth Support (REGS) Rule. BIO supports EPA’s ongoing efforts to improve the efficiency…
BIO Statement on National Academies’ Consensus Study on Human Gene Editing
February 14, 2017
Biotechnology Innovation Organization (BIO) President and CEO James C. Greenwood issued the following statement  regarding the Consensus Study on Human Gene Editing, released today by the Human Gene Editing Initiative of the National Academies…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today